Dose Progression Pathway After 4 weeks at 2.50 mg, many patients advance to: Continuation at 2.50 mg A gradual reduction for maintenance Transition to a lower long-term maintenance dose Your plan remains fully customized
The GLP-1 Dilemma for Employers GLP-1 receptor agonists such as Ozempic and Wegovy have been game-changers in clinical settings
Older adults (there is reduced stomach acid production with age, and acid in the stomach is necessary to absorb vitamin B12)
Ali highlighted that when patients are taking these weight loss medications, they should also implement measures to reduce muscle loss
This powerful antioxidant plays an important role in protecting cells from oxidative stress caused by factors like pollution, UV exposure, toxins, and unhealthy lifestyle habits
It provides a high-protein option that supports heart health and fits into a weight loss diet